<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334249</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-0500</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC research notes</Title><ISOAbbreviation>BMC Res Notes</ISOAbbreviation></Journal><ArticleTitle>The predictive significance of uric acid to high density lipoprotein- cholesterol ratio and uric acid for the severity and mortality of coronavirus disease-19.</ArticleTitle><Pagination><StartPage>277</StartPage><MedlinePgn>277</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">277</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13104-024-06807-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The non-invasive and inexpensive predictive indicators seem to be essential for the evaluation of coronavirus disease-19 (COVID-19) prognosis. Uric acid to high-density lipoprotein-cholesterol ratio (UHR) have been known as inflammatory and metabolic biomarker in some disorders. This study aimed to evaluate the usefulness of serum uric acid (UA) and UHR values on admission as prognostic indicators for the severity and mortality of COVID-19. Regression models were accomplished to assess the association between UA and UHR with the severity and mortality of COVID-19.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study was performed with 424 confirmed COVID-19 patients. The mean UA and UHR values of the severe group and deceased group were statistically higher than those mild group and survivor group, respectively (P &lt; 0.05). Compared to the survivor cases, deceased subjects had lower serum concentrations of HDL-c (p &lt; 0.05). Multivariate logistic regression analysis showed that UHR and UA values statistically are correlated with the severity (OR = 1.20 CI:1.07-1.35, OR = 1.19 CI:1.023-1.381 respectively) and mortality (OR = 10.04 CI:1.50-67.30, OR = 10.73 CI:1.47-87.11, respectively) of COVID-19. Compared with a reference range, serum UA levels ≥ 7.3 mg/dl and a UHR value greater than 0.185 increase the risk of critical care of COVID-19 almost 2.5 and 3.5 times, respectively. In summary, our results revealed that UHR index value and serum UA levels are useful biochemical indicators for predicting the severity and mortality of COVID-19.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rohani-Rasaf</LastName><ForeName>Marzieh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghavidel</LastName><ForeName>Farideh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseini</LastName><ForeName>Hossein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teimouri</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Faculty of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. Teimouri.m@shmu.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Res Notes</MedlineTA><NlmUniqueID>101462768</NlmUniqueID><ISSNLinking>1756-0500</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>268B43MJ25</RegistryNumber><NameOfSubstance UI="D014527">Uric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014527" MajorTopicYN="Y">Uric Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008076" MajorTopicYN="Y">Cholesterol, HDL</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HDL-c</Keyword><Keyword MajorTopicYN="N">UHR</Keyword><Keyword MajorTopicYN="N">Uric acid</Keyword><Keyword MajorTopicYN="N">Uric acid to HDL-c ratio</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334249</ArticleId><ArticleId IdType="pmc">PMC11437878</ArticleId><ArticleId IdType="doi">10.1186/s13104-024-06807-7</ArticleId><ArticleId IdType="pii">10.1186/s13104-024-06807-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xie LX. Interpretation of the 7th edition of the diagnosis and treatment guidelines of coronavirus disease 2019 in China: Progress and challenges. Chronic Dis Transl Med. 2020;6(2):75–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177117</ArticleId><ArticleId IdType="pubmed">32328337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–93.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Samprathi M, Jayashree M. Biomarkers in COVID-19: an up-to-date review. Front Pead. 2021;8:607647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8042162</ArticleId><ArticleId IdType="pubmed">33859967</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P et al. Comorbidity and its impact on patients with COVID-19. SN comprehensive clinical medicine. 2020;2(8):1069–76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855377</ArticleId><ArticleId IdType="pubmed">32845042</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohani-Rasaf M, Mirjalili K, Vatannejad A, Teimouri M. Are lipid ratios and triglyceride-glucose index associated with critical care outcomes in COVID-19 patients? PLoS ONE. 2022;17(8):e0272000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9342722</ArticleId><ArticleId IdType="pubmed">35913952</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26316329</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdi F, Baghaei MH, Baniasad A, Naghibzadeh-Tahami A, Najafipour H, Gozashti MH. Investigating the relationship between serum uric acid to high‐density lipoprotein ratio and metabolic syndrome. Endocrinol Diabetes Metabolism. 2022;5(1):e00311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8754234</ArticleId><ArticleId IdType="pubmed">34705333</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral A, Sahin T, Turker F, Kocak E. Relationship between serum uric acid levels and nonalcoholic fatty liver disease in non-obese patients. Medicina. 2019;55(9):600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6780528</ArticleId><ArticleId IdType="pubmed">31533345</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimi-Sakak F, Maroofi M, Rahmani J, Bellissimo N, Hekmatdoost A. Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants. BMC Cardiovasc Disord. 2019;19(1):1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792332</ArticleId><ArticleId IdType="pubmed">31615412</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Liu J, Xu Y. Effects of uric acid on diabetes mellitus and its chronic complications. International journal of endocrinology. 2019;2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6815590</ArticleId><ArticleId IdType="pubmed">31737070</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartziokas K, Papaioannou AI, Loukides S, Papadopoulos A, Haniotou A, Papiris S, et al. Serum uric acid as a predictor of mortality and future exacerbations of COPD. Eur Respir J. 2014;43(1):43–53.</Citation><ArticleIdList><ArticleId IdType="pubmed">23645404</ArticleId></ArticleIdList></Reference><Reference><Citation>Motamedi H, Ari MM, Dashtbin S, Fathollahi M, Hossainpour H, Alvandi A, et al. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages. Int Immunopharmacol. 2021;96:107763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8101866</ArticleId><ArticleId IdType="pubmed">34162141</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufour I, Werion A, Belkhir L, Wisniewska A, Perrot M, De Greef J, et al. Serum uric acid, disease severity and outcomes in COVID-19. Crit Care. 2021;25(1):1–12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8201458</ArticleId><ArticleId IdType="pubmed">34127048</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Wu X, Zhou C-l, Wang Y-m, Song B, Cheng X-b, et al. Uric acid as a prognostic factor and critical marker of COVID-19. Sci Rep. 2021;11(1):1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8423827</ArticleId><ArticleId IdType="pubmed">34493750</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto TI, Kurniawan A. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(5):1463–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395301</ArticleId><ArticleId IdType="pubmed">32771919</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi GJ, Kim HM, Kang H. The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews. J Lipid Atherosclerosis. 2020;9(3):435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521969</ArticleId><ArticleId IdType="pubmed">33024735</ArticleId></ArticleIdList></Reference><Reference><Citation>Atmosudigdo IS, Lim MA, Radi B, Henrina J, Yonas E, Vania R, et al. Dyslipidemia increases the risk of severe COVID-19: a systematic review, meta-analysis, and meta-regression. Clin Med Insights: Endocrinol Diabetes. 2021;14:1179551421990675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8842489</ArticleId><ArticleId IdType="pubmed">35173508</ArticleId></ArticleIdList></Reference><Reference><Citation>Feingold KR, Grunfeld C. The role of HDL in innate immunity 1. J Lipid Res. 2011;52(1):1–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2999920</ArticleId><ArticleId IdType="pubmed">20944062</ArticleId></ArticleIdList></Reference><Reference><Citation>Xuan Y, Zhang W, Wang Y, Wang B, Xia F, Zhang K, et al. Association between Uric acid to HDL cholesterol ratio and Diabetic complications in men and Postmenopausal women. Metabolic Syndrome and Obesity: Diabetes; 2023. pp. 167–77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9869791</ArticleId><ArticleId IdType="pubmed">36760595</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W, Liang A, Shi P, Yuan S, Zhu Y, Fu J, et al. Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels. BMC Gastroenterol. 2022;22(1):196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9027046</ArticleId><ArticleId IdType="pubmed">35448944</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Revista Da Associação Médica Brasileira. 2019;65:9–15.</Citation><ArticleIdList><ArticleId IdType="pubmed">30758414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudiro S, Satino S, Setyorini Y, Ardesa YH, Darmawan RE. Zero Mortality During Covid-19 Outbreak: A Review in 418 Workers at a Health University. (JKG) Jurnal Keperawatan Global. 2023:13–21.</Citation></Reference><Reference><Citation>Joosten LA, Crişan TO, Bjornstad P, Johnson RJ. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol. 2020;16(2):75–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7075706</ArticleId><ArticleId IdType="pubmed">31822862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Guo Y, Lin J, Zeng Y, Wang J, Li M, et al. Association of serum uric acid levels with COVID-19 severity. BMC Endocr Disorders. 2021;21(1):97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8106517</ArticleId><ArticleId IdType="pubmed">33964922</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan K, Pattharanitima P, Piani F, Johnson RJ, Uribarri J, Chan L, et al. Prevalence and outcomes associated with hyperuricemia in hospitalized patients with COVID-19. Am J Nephrol. 2022;53(1):78–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8805068</ArticleId><ArticleId IdType="pubmed">34883482</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Lu C, Gu H-Q, Li Y, Zhang G, Lio J, et al. Serum uric acid concentrations and risk of adverse outcomes in patients with COVID-19. Front Endocrinol. 2021;12:633767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134697</ArticleId><ArticleId IdType="pubmed">34025575</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pan Y, Yin Y, Chen W, Li X. Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis. Virol J. 2021;18(1):157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314261</ArticleId><ArticleId IdType="pubmed">34315474</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktas G, Kocak MZ, Bilgin S, Atak BM, Duman TT, Kurtkulagi O. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–102.</Citation><ArticleIdList><ArticleId IdType="pubmed">31615320</ArticleId></ArticleIdList></Reference><Reference><Citation>Park B, Jung DH, Lee YJ. Predictive value of serum uric acid to HDL cholesterol ratio for Incident Ischemic Heart Disease in non-diabetic koreans. Biomedicines. 2022;10(6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9219787</ArticleId><ArticleId IdType="pubmed">35740443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui Z, Qiu X, Li HZ, Cui JJ, Sun YY. Association between serum uric acid to HDL-Cholesterol ratio and nonalcoholic fatty liver disease risk among Chinese adults. Biomed Environ Sci. 2023;36(1):1–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">36650677</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>